Correction to: Respir Res
https://doi.org/10.1186/s12931-020-1275-8
After publication of our article [1], we have been notified that an extra alpha symbol (α) was mistakenly added at the beginning of the title.
The original article has been corrected.
Reference
Krempaska, et al. Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls. Respir Res. 2020;21:25. https://doi.org/10.1186/s12931-020-1275-8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Krempaska, K., Barnowski, S., Gavini, J. et al. Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls. Respir Res 21, 29 (2020). https://doi.org/10.1186/s12931-020-1304-7
Published:
DOI: https://doi.org/10.1186/s12931-020-1304-7